Sydney-based MedTech company Next Science (ASX: NXS) has reported a bumper result with its annual sales, reaching $33.7 million, a 90% increase compared to the previous year. This surge is primarily attributed to the expansion in the Wound Care and Surgical segments, driven by a strategic focus on direct sales and the successful implementation of
Read More
Australia’s growing ageing population (older Aussies are expected to make up 23% of the population by 2026) is not free of health issues, ranging from obesity to cracking hips. This has benefitted some medical fields more than others. Over the past decade, there has been a 140% increase in knee replacement surgeries, shooting up to
Read More